NCT01613027View on ClinicalTrials.gov

An Observational Study of MabThera in Participants With Severe Active Rheumatoid Arthritis

CompletedOBSERVATIONAL
Enrollment

135

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL

Rituximab

Rituximab administered according to prescribing information and normal clinical practice.

Trial Locations (14)

11521

Athens

11527

Athens

14527

Athens

16673

Voula

26335

Pátrai

57010

Thessaloniki

71110

Heraklion

155 62

Athens

124 62

Haidari

455 00

Ioannina

411 10

Larissa

265 04

Pátrai

544 65

Thessaloniki

546 42

Thessaloniki

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01613027 - An Observational Study of MabThera in Participants With Severe Active Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter